Ardelyx Inc (ARDX)
7.815
+0.02
(+0.32%)
USD |
NASDAQ |
May 17, 16:00
7.815
0.00 (0.00%)
After-Hours: 18:36
Ardelyx Gross Profit (Quarterly): 38.90M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 38.90M |
December 31, 2023 | 29.29M |
September 30, 2023 | 48.70M |
June 30, 2023 | 18.84M |
March 31, 2023 | 9.832M |
December 31, 2022 | 41.02M |
September 30, 2022 | 4.254M |
June 30, 2022 | 2.388M |
March 31, 2022 | 0.383M |
December 31, 2021 | 1.029M |
September 30, 2021 | 1.173M |
June 30, 2021 | 1.313M |
March 31, 2021 | 5.582M |
December 31, 2020 | 1.805M |
September 30, 2020 | 2.713M |
Date | Value |
---|---|
June 30, 2020 | 1.695M |
March 31, 2020 | 1.213M |
December 31, 2019 | 2.25M |
September 30, 2019 | 2.413M |
June 30, 2019 | 0.018M |
March 31, 2019 | |
December 31, 2018 | 0.085M |
September 30, 2018 | 0.17M |
June 30, 2018 | 0.03M |
March 31, 2018 | 1.856M |
December 31, 2017 | 33.60M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.018M
Minimum
Jun 2019
48.70M
Maximum
Sep 2023
10.74M
Average
2.400M
Median
Gross Profit (Quarterly) Benchmarks
Nektar Therapeutics | 13.10M |
Rigel Pharmaceuticals Inc | 27.51M |
Vistagen Therapeutics Inc | -- |
Karyopharm Therapeutics Inc | 31.22M |
Adverum Biotechnologies Inc | -- |